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In this study, we identified the main hydroxylated polychlorinated biphenyls (OH-PCBs) and
other chlorinated phenolic compounds and we determined their relative concentrations in whole
blood from 13 male and 17 female Inuit from northern Quebec, Canada, and from a pooled
whole blood sample from southern Quebec. We also determined concentrations ofpolychlorinat-
ed biphenyls (PCBs). Total OH-PCB concentrations were variable among the Inuit samples,
ranging over 2 orders ofmagnitude (0.117-11.6 ng/gwhole blood wetweight). These concentra-
dions were equal to and up to 70 times those found forthe southern Quebec pooledwhole blood
sample. Geometric mean concentrations oftota OH-PCBs were 1.73 and 1.01 nglgwhole blood
for Inuit men andwomen, respectively, and 0.161 nglgwhole blood for the southern population
pool. There are limited data available for comparison, but the levels of OH-PCBs in Imuit are
higher thn thosepreviouslyreported in the literature for other populations. There was a signifi-
cant correlation (p < 0.005) between OH-PCBs and PCBs (r= 0.84) and both correlated signifi-
candy (p < 0.005) with age (r= 0.68 and0.78, respectively). The ratio ofOH-PCBs to PCBs was
lower in Inuit (0.11) than in the southern Quebec pool (0.33). There is no apparent explanation
for the difference. There was considerable variability in the congener pattem of the identified
OH-PCBs. The main metabolite, 4-OH-CB109 (4-0H-2,3,3',4',5-pentachlorobiphenyl), consti-
tuted 12-62% of the total OH-PCBs in the samples. Pentachlorophenol (PCP) was the domi-
nant phenolic compound in blood, constituting 46% (geometric mean) ofthe total quantitated
chlorinated phenolic compounds. PCP concentrations in Imuit blood ranged from 0.558 to 7.77
ng/gon awetweight basis. All buttwo Inuitsamples hadlower concentrations than the southern
Quebec pool (6.29 ng/g). The possible role of OH-PCBs in mediating PCB-induced adverse
effects needs to be investigated fiuther. Key word.: Canadian Iuit, chlorinated phenolic com-
pounds, hydroxylated metabolites, OH-PCBs, PCBs, pentachlorophenol, polychlorinated
biphenyls. EnvironHealt Prspect108:611-616 (2000). [Online25 May2000]
httpnx/ehpnetl.niehs.nih.fov/docs/2000/108p611-616sandau/abstra.thtml
Polychlorinated biphenyls (PCBs) have been
extensively studied since their discovery as
environmental pollutants over 30 years ago
(1). Their persistence in biota is well known
but the mechanism of their adverse effects
on biologic systems is still not completely
understood. Some of their toxicity may be
linked to the biotransformation products of
PCBs (2). PCBs are biotransformed by a
diverse enzyme system, the cytochrome
P450 monooxygenases. Most of the known
metabolic pathways involve the initial for-
mation of hydroxylated metabolites. Even
one of the more recalcitrant PCBs, CB153,
is metabolized in vitro and in vivo to a num-
ber of phenolic metabolites (3-5). Phenolic
metabolites can be excreted unchanged, as
they were first discovered in the excreta of
Baltic seals and Guillemots (6), or further
conjugated with glucuronic acid or sulfate
(7). The introduction of a hydroxyl group
increases the polarity of the PCB and
facilitates excretion. Ifthe hydroxyl group is
para to the phenyl-phenyl bond and has
adjacent chlorine atoms, the structure resem-
bles the prohormone, thyroxin (T4) (8). This
structural similarity allows hydroxylated
polychlorinated biphenyls (OH-PCBs) to
bind with high affinity to one of the thyroid
hormone transport proteins, transthyretin
(TTR) (9-12). For example, 4-OH-3,3',4,5'-
tetrachlorobiphenyl, a metabolite of CB77,
has a binding affinity to TTR 4 times
stronger than that ofT4 (9), and can disrupt
thyroid hormone and retinol (vitamin A)
transport (13). This is the presumed mecha-
nism by which OH-PCBs are selectively
retained in plasma and is a possible mecha-
nism of PCB toxicity (14). This type of
interaction is not limited to OH-PCBs.
Pentachlorophenol (PCP) binds with 2
times the affinity of T4 to TTR (15), indi-
cating that other chlorinated phenolic com-
pounds may also be interfering in thyroid
hormone transport.
Some Inuit consume traditional food-
stuffs consisting of fatty tissues from sea
mammal species such as ringed seal and belu-
ga (16-18). Ringed seal blubber, beluga skin,
and beluga blubber in northern Canada con-
tain average total PCB concentrations of
1,283, 145, and 5,000 ng/g wet weight,
respectively (19,20), which is much higher
than that in the diet ofthe general population
(21). Thus, the Inuit population may be
exposed to large doses of PCBs. In one
study, mean PCB blood levels in Inuit were
30 times those of a southern population
(22). An increased PCB body burden could
result in the increased formation ofmetabo-
lites due to induction of the P450 system.
Increased levels ofmetabolites may be signif-
icant enough to disrupt thyroid hormone
transport. Alterations of thyroid hormone
status have been proposed as a mechanism of
action by which PCBs would induce adverse
neurodevelopmental effects (23). It is there-
fore of interest to study the concentrations
ofOH-PCB metabolites in the Inuit popula-
tion as a first step to evaluate their possible
implications mediating PCB-induced health
effects. Hydroxylated PCBs have never been
studied in the Arctic environment and little
is known about levels and patterns in
humans. There are only two other published
studies on OH-PCB metabolite concentra-
tions in human blood [from Sweden and
Latvia (14,24)].
Materials and Methods
During fall 1992, 499 Inuit adults living in
Nunavik (Northern Quebec, Canada) partici-
pated in the Sante Quebec Health Survey.
After they signed an informed consent form,
we drew a 30-mL blood sample by venous
puncture for organochlorine determination.
We randomly selected 30 subsamples ofthese
499 samples for chlorinated phenolic com-
pound and additional PCB residue analysis.
The Laval University Medical Centre (Sainte-
Foy, Quebec) donated a southern Quebec
general population sample of pooled whole
blood for comparison to the Inuit population.
The chosen nomenclature for number-
ing hydroxylated PCBs or their derivatized
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analogs, methoxylated PCBs, is slightly dif-
ferent from general International Union of
Pure and Applied Chemistry (IUPAC)
guidelines (25). The OH- or MeO- groups
are not given numbering priority. Rather, the
chlorine pattern on the biphenyl rings deter-
mines the congener number according to the
IUPAC PCB numbering rules (25), with cor-
rections by Guitart et al. (26), and the OH-
or MeO- groups are numbered thereafter.
This facilitates direct structural comparison
with PCBs because the IUPAC numbering
system is sowell established andfamiliar.
We used the following 13C12-1abeled stan-
dards [acquired fromWellington Laboratories
(Guelph, Ontario, Canada)] as recovery inter-
nal standards for OH-PCB determination:
4'-OH-CB120 (4'-OH-2,3',4,5,5'-pen-
tachlorobiphenyl); 4'-OH-CB159 (4'-
OH-2,3,3',4,5,5'-hexachlorobiphenyl);
4'-OH-CB172 (4'-OH-2,2',3,3',4,5,5'-
heptachlorobiphenyl); and 4-OH-CB187
(4-OH-2,2',3,4',5,5',6-heptachloro-
biphenyl). We purchased PCP (13C6) from
Cambridge Isotope Laboratories (Andover,
MA) and used it for PCP quantitation. We
added a synthesized performance standard,
4'-Me-4-MeO-2,3,3',5,6-pentachloro-
biphenyl, to all phenolic compound frac-
tions before mass spectral analysis. We used
labeled PCBs (13C12-CB28, -52, -118, -153,
-180, and -194) as recovery standards and
13Ci2-CB138 as the performance standard
for PCB analysis by the external standard
method. The 13C12-PCB standards were pur-
chasedfrom Cambridge Isotope Laboratories.
Whole blood samples (mass range
1.54-5.76 g) were spikedwith 13C 2 recovery
standards before extraction. The standards
consisted of a PCB mixture (13C12-CB28,
-52, -118, -153, -180, and -194; 10 pL, 2.5
ng/lpL), a OH-PCB mixture (13C12-4'-OH-
CB120, 4'-OH-CB159, 4'-OH-CB172,
and 4-OH-CB187; 20 pL, 100 pg/lpL), and
PCP (13C6; 100 pL, 100 pg/pL). The
samples were then extracted using the
Wallenberg plasma extraction method, as
described elsewhere (14,27), with the follow-
ing modifications. The organic phase from
the potassium hydroxide partitioning, which
contains the neutrals, was reduced in volume
and applied to a Florisil column (8 g, 1.2%
deactivated). The PCBs were collected in
one fraction of 75 mL dichloromethane
(DCM):hexanes (1:1) then reduced in vol-
ume and applied to asilica/sulfuric acid (3 g,
22%) column to remove coextracted bio-
genic components. The PCBs were eluted in
50 pL DCM:hexanes, reduced to final vol-
ume (50 pL) by rotoevaporation, and spiked
with performance standard (13CG2; CB138,
5 pL, 2.0 ng/lpL) for mass spectral analysis.
The partitioned phenolic compounds
were acidified and back extracted with
hexanes, dried over sodium sulfate, and
derivatized with diazomethane. Wegenerated
diazomethane as needed from nitrosomethy-
lurea precursor, as described elsewhere (28).
The derivatized compounds were then
cleaned up on a silica/sulfuric acid (5 g,
22%) column and eluted with 50 mL
DCM:hexanes. We reduced the samples in
volume by rotoevaporation and brought the
samples down to final volume (25 pL) by a
gentle stream of nitrogen. All samples were
then spiked with a performance standard
(4'-Me-4-MeO-2,3,3 ',5,6-pentachloro-
biphenyl, 5 pL, 200 pg/pL) before analysis.
Analyses were completed on a Hewlett
Packard 5890A Series II gas chromatograph
Hewlett Packard, Atlanta, GA) equipped
with an HP 7673A automatic injector and a
Hewlett Packard 5988A mass spectrometer.
We used helium as the carrier gas; we set the
head pressure at 80 kPa. All injections (2 pL)
were made in splitless mode onto a DB-5
column [(5%-phenyl)-methylpolysiloxane,
30 m x 0.25 pm i.d., 0.25-pm film thick-
ness; J&W Scientific, Inc., Folsom, CA).
The injector temperature was set at 250°C.
We performed mass spectrometry with
selected ion monitoring in electron capture
negative ionization (ECNI) mode using
methane (99.99% pure) as the reagent gas
for the chlorinated phenolic fraction. The
reagent gas source pressure was 2.5 x 10-4
torr at the inlet and the source temperature
was 1400C. The GC temperature program
for the derivatized phenolic compounds was
as follows: 800C for 2 min, ramp 10°C/min
to 2500C, hold for 5 min, then ramp
50C/min to 300°C. We analyzed the pheno-
lic compound fraction using ECNI because
ofthe presence ofresidual biogenic material
that interferes with the analysis in electron
impact (EI) mode. The PCB fraction was free
ofbiogenic contamination, allowing analysis
ofthe fraction using selected ion monitoring
in El mode. The electron energy was 70 eV
and the source temperature was 200°C. The
GC temperature program for the PCB analy-
siswas 100°C for3 min, 10°C/min to 1800C,
and then2.5°C/min to 280°C.
Because analysis was carried out on
methylated OH-PCBs, we used a standard
mixture of MeO-PCBs. The MeO-PCB
mixture included 4'-MeO-2,3',4,5,5'-pen-
tachlorobiphenyl (4'-MeO-CB120);
4'-MeO-2,3,3',4,5'-pentachlorobiphenyl
(4'-MeO-CB107); 4-MeO-2,2',3,4',5,6,6'-
heptachlorobiphenyl (4-MeO-CB188);
3-MeO-2,2',4,4',5,5'-hexachlorobiphenyl
(3-MeO-CB153); 4-MeO-2,2',3,4',5,5'-
hexachlorobiphenyl (4-MeO-CB146);
3'-MeO-2,2',3,4,4',5'-hexachlorobiphenyl
(3'-MeO-CB138); 4'-MeO-2,2',3,3',4,5'-
hexachlorobiphenyl (4'-MeO-CB130); 3'-
MeO-2,2',3,4',5,5',6-heptachlorobiphenyl
(3'-MeO-CB187); 4'-MeO-2,2',3,3',4,5',6-
heptachlorobiphenyl (4'-MeO-CB175);
4'-MeO-2,3,3',4,5,5'-hexachlorobiphenyl
(4'-MeO-CB159); 3'-MeO-2,2',3,4,4',5,5'-
heptachlorobiphenyl (3'-MeO-CBI180);
4'-MeO-2,2',3,3',4,5,5'-heptachloro-
biphenyl (4'-MeO-CB172); and 4-MeO-
2,3,3',4',5,5',6-heptachlorobiphenyl
(4-MeO-CB193). The MeO-PCBs were
supplied by A. Bergman (Wallenberg Labo-
ratories, Stockholm, Sweden), and synthe-
sized as described elsewhere (29). We used
the MeO-PGBs for quantitation by the
external standard method.
We used a serial dilution of the MeO-
PCB mixture for quantitation. We generated
response factors relative to the performance
standard (RRFs) for each ofthe compounds
in the standard mixture. The RRFs were
then used to quantitate all identified and
unidentified OH-PCBs in each sample by
the external standard method, with volume
correction using the performance standard.
Identified compoundswere quantitated using
their RRF. Structures were considered con-
firmed if they had identical spectra and
matching retention times on three GC
columns with varying polarities (DB5,
DB1701, and DB210; J&WScientific, Inc.).
We characterized unidentified compounds by
full scan mass spectrometry to determine the
chlorination pattern. The average RRFs for
that chlorination pattern were used for quan-
titation for the unidentified compounds. The
RRFs for compounds with a given chlorina-
tion and methoxy group substitution were
comparable. For example, the RRFs for the
para-methoxylated heptachlorobiphenyls were
all within 10% ofthe average RRF. We deter-
mined recoveries using the 13C12 OH-PCB
standards and 4'-Me-4-MeO-2,3,3',5,6-pen-
tachlorobiphenyl as the performance standard.
PCP was quantitated by isotope dilution
using the 13C6 internal recoverystandard cor-
recting for the 3.4% contribution of native
PCP (m/z = 280 amu) to the main ion ofthe
13C6standard (n/z = 286 amu) duster.
PCBs were quantitated on a congener-
specific basis by the external standard
method using an Aroclor 1242:1254:1260
(1:1:1) secondary quantitation standard solu-
tion calibrated against primary standard PCB
congener solutions provided by the National
Research Council of Canada (Marine
Analytical Chemistry Standards Program,
Halifax, Nova Scotia, Canada). We deter-
mined concentrations ofcongeners forwhich
standard solutions were not available in the
Aroclor mixture by GC using flame ioniza-
tion detection (30). We purchased Aroclor
from Monsanto (St. Louis, MO).
PCBs were previously determined in
these samples by the Quebec Toxicology
Centre (Sainte-Foy, Quebec, Canada) using
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plasma as the tissue for analysis. Because of
Aroclor 1254 contamination in one of our
rotoevaporators, 15 of the 30 whole blood
samples were irreclaimable for PCB quanti-
tation. We compared the 15 whole blood
samples not contaminated with Aroclor
1254 to the previous plasma analyses.
Concentrations ofall previously quantitated
congeners (CB28, CB52, CB99, CB1O1,
CB105, CB118, CB128, CB138, CB153,
CB156, CB170, CB180, CB183, and
CB187) and the sum ofcongeners in plasma
were highly correlated (r > 0.97) to the
whole blood concentrations using least-
squares regression analysis. The regression
analysis for CB153 and total PCBs are given
as examples in Figure 1. Thus, the previous
PCB plasma concentrations for the 15 sam-
ples not quantitated in our lab were adjusted
by applying a correction factor from the
regression analysis. We used the adjusted
PCB concentrations and the values deter-
mined in the 15 whole blood samples in the
present study for comparison to OH-PCB
concentrations and for subsequent statistical
analysis. Aroclor contamination had no
effect on the quantitation of OH-PCBs in
the contaminated samples because PCBs
elute earlier and have no fragment ions that
interfere with the detection ofOH-PCBs.
All solvents were residue analysis grade
and were purchased from EM Science
(Gibbstown, NJ). Florisil (Pesticide Analysis
Residue grade, 60-100 mesh) was purchased
from BDH, Inc. (Toronto, Ontario, Can-
ada). Merck Silica gel (Grade 60, 70-230
mesh, 60A) was purchased from Aldrich
Chemical Company, Inc. (Milwaukee, WI).
We purchased trace-metal-grade sulfuric acid
from FisherScientific (Pittsburgh, PA).
Results
Whole blood recoveries of OH-PCBs were
variable, ranging from 50 to 105%. The
mean recoveries for 13C12- 4'-OH-CB120,
-4'-OH-CB159, -4'-OH-CB172 and -4-
OH-CB187 were 82, 69, 72, and 76%,
respectively. This was the first study to use
13C12-labeled OH-PCBs for accurate
OH-PCB quantitation. PCB recoveries had a
slightlylowermean recoveryof60%. All PCB
and OH-PCB concentrations were conse-
quentlyrecoverycorrected.
An example chlorinated phenolic ECNI-
MS full scan chromatogram is given in
Figure 2. The major peaks are identified
when known. The OH-PCB fraction in
Inuitwhole blood contained > 30 congeners,
ofwhich 11 were positively identified with
authentic standards. Positive identification is
based on identical mass spectra using full
scan ECNI mass spectrometry and matching
retention times using three GC columns
with varying polarities (results not shown).
All identified congeners are listed in Table 1.
The congeners constituted between 59 and
81% of the total OH-PCBs in the samples
(mean = 70%).
We did notdetermine the lipid contentof
the whole blood samples. Therefore, all con-
centrations hereafter are expressed on awhole
blood wet weight basis. The chemical residue
data were not normally distributed. Log-
transformed data approached normal distrib-
ution; therefore, log-transformed data were
used in all statistical analyses and geometric
mean values were used unless otherwise stat-
ed. The geometric mean concentrations in
men and women of all identified congeners
and their range ofvalues are listed in Table 1.
Women consistently had lower geometric
mean concentrations of all the chlorinated
phenolic compounds quantitated, but the
difference was statistically significant between
men and women using Student's t-test
onlyfor PCP.
The concentrations in the pooled
sample are equivalent to arithmetic mean
70L
8
0 10 20 0 40 80
Plus. (n/mL) PlIm.. (nglmL)
Figure 1. The regression analysis of (A) CB153 and (8) total PCBs, showing thatthe concentrations previ-
ously determined in plasma are significantly correlated to those in whole blood determined in this study.
The correction factor was developed by regression ofthe whole blood concentration versus the plasma
concentration from the previous analyses. The equation for the least-squared regression can then be
used to adjust the plasma values for the samples into whole blood equivalents. This was done for each
congener independently and forthe sum of all quantitated PCBs. (A) r= 0.97, p< 0.005; y= 0.76x - 0.23. (B)
r= 0.98, p<0.005; y=0.74x+ 5.7.
concentrations. The arithmetic mean of the
total OH-PCBs in Inuit whole blood was
1.89 times greater than the geometric mean.
Therefore, the difference in geometric mean
values between pop'ulations is probably an
overestimate ofthe geometric mean and the
differences in concentrations are even greater
than indicated in Table 1.
PCP was the main chlorinated phenolic
compound in the Inuit whole blood. It con-
tributed between 14 and 89% of the total
chlorinated phenolic compounds quantitat-
ed. The concentration of PCP ranged from
0.558 to 7.77 ng/g with a geometric mean of
2.02 ng/g wet weight. The pooled whole
blood sample from the southern population
had higher PCP levels than all but two Inuit
samples analyzed, with a concentration of
6.29 ng/g. PCP composed 97% ofthe total
quantitated chlorinated phenolic com-
pounds in the southern population.
The major OH-PCB congeners varied
considerably among individuals. The mean
ratios of the five main congeners to total
OH-PCBs are shown in Figure 3, with bars
representing the range. The main congener
identified in Inuit whole blood (21 of 30
samples) was 4-OH-CB109, with ageometric
mean concentration of 0.266 ng/g and a
range of 0.015-2.55 ng/g. This congener is
probably a mixture oftwo congeners, 4-OH-
CB109 (4-OH-2,3,3',4',5-pentachloro-
biphenyl) and 4'-OH-CB107, because they
coelute and because separation was not
achieved with the DB-5 column used in this
study. This peak was quantitated using only
4'-OH-CB107 as the quantitation standard
because 4-OH-CB109 was not commercially
available. Thepeak is assumed to bepredomi-
nantly 4-OH-CB109 because it is the domi-
nating compound of the mixture in human
plasma at a 5:1 excess (14,31). However, con-
sidering pattern variability this would need to
beconfirmed foreachsample in the future.
.s
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Figure 2. GC-MS (ECNI) SIM chromatogram of
the OH-PCBs and other chlorinated phenolic
compounds from Inuit whole blood analysis. PCP
was truncated to fit on the scale shown. The
chromatogram can only be used as a qualitative
graph because each compound fragments differ-
ently and the response varies for compounds
with different chlorination patterns. Forthis sam-
ple, only two internal standards (IS) and the
performance standard (PS) were added for illus-
trative purposes.
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In eight of the samples, 4-OH-CB187
was the dominating congener. It ranged
from 0.022 to 2.26 ng/g with a geometric
mean of0.202 ng/g for all samples. This was
the main metabolite in plasma determined
in previous studies (14,32,33). The main
metabolite in the remaining sample was 4-
OH-CB146. The geometric mean concen-
tration for 4-OH-CBI146 in all samples was
0.149 ng/g and ranged from 0.010 to 1.88
ng/g. The metabolite may be formed from
CB146 via a direct oxygen insertion or from
CB153 or CB138 via a National Institutes
ofHealth (NIH) shift ofCl in the hydroxy-
lation step. If a metabolite is formed by a
direct oxygen insertion, it would retain the
precursor PCB number. Ifthe metabolite is
produced via an NIH shift of Cl, the
metabolite PCB number will be different
from thatoftheparent PCB.
Total quantitated OH-PCBs ranged
from 0.117 to 11.6 ng/g with a geometric
mean value of1.27 ng/g. Total OH-PCBs in
individuals were equal to and up to 70 times
that of the southern Quebec pooled sample
(0.161 ng/g). Geometric mean CB153 and
geometric mean total PCB concentrations in
combined Inuit samples were 2.37 ng/g
(range 0.263-13.9 ng/g) and 15.2 ng/g
(range 1.19-65.9 ng/g), respectively.
Concentrations in the southern Quebec
pooled sample were 0.074 ng/g for CB153
and 0.488 ng/g for total PCBs. The mean
ratio of total OH-PCBs to total PCBs was
0.11 (range 0.02-0.45) for combined Inuit
and 0.33 for the southern Quebec pooled
sample, demonstrating the importance of
OH-PCBs in the total PCB-related com-
pounds in blood. The concentration of the
five main OH-PCB metabolites relative to
Table 1. Concentration of PCP and hydroxylated metabolites (ng/g whole blood wet weight x 103) in Inuit
whole blood.,
Age (years)
PCP
4'-OH-CB120
4-0H-CB109b
3-OCHCB153b
4-OH-CB146b
3'-OH-CB138
4'-OH-CB130
3'-OH-CB187
4-0H-CB187b
3'-OH-CB180
4'-OHCB172b
4-OH-CB193
Sum congenersb
Sum identified
Sum all OH-PCBs
Sum PCBs
CB-153
Males (n= 13)
Range
GM Min Max
38 18 66
2,740 1,350 7,770
12 3 67
314 39 2,550
85 5 537
219 10 1,750
37 3 225
15 1 506
17 1 213
293 22 1,840
17 2 134
74 5 443
41 3 659
1,040 88 6,740
1,210 119 7,520
1,730 162 10,100
12,900 2,070 65,900
3,120 460 13,900
GM
38
1,590
7
234
49
111
20
4
11
152
8
38
26
614
712
1,010
7,940
1,960
Females (n= 17)
Range
Min Max
18
558
< 1
15
4
10
2
<1
<1
27
1
4
2
59
87
117
1,190
263
72
7,510
39
1,470
830
1,880
401
47
167
2,260
239
740
95
7,070
8,060
11,600
38,100
9,510
Southern
population
pool
6,290
3
25
2
8
2
<1
< 1
31
<1
11
18
76
82
161
488
74
Abbreviations: GM, geometric mean; max, maximum; min, minimum.
'Total OH-PCBs, sumfive main congeners, and sum identified congeners are given for comparison with previous studies.
1'Sumfive main congeners:4-OH-CB319 +3-OH-CB153 +4-OH-CB146 +4-OH-CB187 +4'-OH-CB172.
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Figure 3. Ratio ofthe five main metabolites to total OH-PCBs and to CB153. Mean ratios are given for com-
bined male and female Inuitsamples, and error bars representthe range.
total OH-PCBs and CB153 for both Inuit
and the southern Quebec pooled sample are
shown graphically in Figure 3.
Plots of log-normalized concentrations
versus age are shown in Figure 4. Both PCBs
(r= 0.78) and OH-PCBs (r= 0.68) were sig-
nificantly (p < 0.005) correlated with age. As
seen by the similar slopes, total OH-PCBs
and total PCBs were also significantly corre-
lated (r= 0.84,p < 0.005).
Discussion
The only human blood analyzed previously
for OH-PCBs and other chlorinated pheno-
lic compounds was plasma from the Swedish
population (14,31). PCP was described as
the dominant compound in these studies,
but levels were not given. The geometric
mean PCP concentration in the Inuit sam-
ples was 2.02 ng/g, approximately 3 times
lower than in the southern Quebec pooled
sample. Geyer et al. (34) measured PCP in
two different general populations in
Germany and found average concentrations
of approximately 20 ng/g wet weight. The
study did not indicate if the samples ana-
lyzed were whole blood or plasma, so the
comparison oflevels with the present results
may be incorrect. However, a recent study
documented levels of PCP in men from
Sweden and Latvia between 170 and 1,800
ng/g on a plasma lipid weight basis (24).
When the Swedish data are approximated to
plasma equivalents, these levels are the same
order ofmagnitude and have a similar range
as those for the Inuit and the southern
Quebec pooled whole blood samples. The
plasma equivalent was estimated by assuming
thatwhole blood is approximately halfplasma
by weight and that the average plasma lipid
levels in thepopulation areapproximately 1%.
Although the concentration of PCP is
lower in Inuit than that measured in the
southern Quebec pooled whole blood sam-
ple, it may still play a role in the disruption
ofthyroid hormone transport. PCP binds to
TTR with twice the affinity of the native
100 .f ' ..........
..........
il
....
U , 1~~i '~~'~< UOH-PCBS
0.1
10 20 30 40 50 60 70 80
Age(years)
Figure 4. Log-normalized concentrations versus
age (in years) for total PCBs and total OH-PCBs.
PCBs, Y = 0.022x + 3.10; r = 0.78; p < 0.005.
OH-PCBs, Y= 0.023x+ 2.17; r= 0.68; p<0.005.
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hormone (15) and is responsible for
14-89% of the total phenolic comnpounds
quantitated. Geyer et al. (34) calculated the
half-life of PCP as approximately 19 days
and concluded that the German cohort's
calculated intake ofPCP exceeded the elimi-
nation rate and approximated a bioconcen-
tration factor of 1.4 for blood. This is likely
due to binding with TTR and explains the
high levels of PCP found in blood. Con-
sidering the significance ofPCP in the chlori-
nated phenolic fraction, further investigation
of PCP and its possible effects on thyroid
hormone transport is required, especially for
southern populations, where levels of PCP
far exceed OH-PCBs and other chlorinated
phenolic compounds.
Another major compound in the Inuit
whole blood chromatogram is an unidenti-
fied chlorinated phenolic compound that
elutes just before the OH-PCBs. The major
ion cluster for this compound, using the
given mass spectrometry conditions, has an
isotope pattern indicative ofa hexachlorinat-
ed compound. Therefore, the levels were
approximated using the C16 response factor
from the OH-PCB standard mixture. Based
on approximate concentrations, the com-
pound accounts for 1-17% of total chlori-
nated phenolic compounds in the Inuit.
Levels occasionally exceeded those of the
main OH-PCBs. Further work on the iden-
tification and accurate quantitation of this
unknown compound is currently underway.
The chromatogram ofthe phenolic com-
pound fraction consists of > 30 peaks that
were identified as hydroxylated metabolites
of PCBs based on their mass spectra. These
represent 20% of the total chlorinated phe-
nolic compounds, on average, in Inuit whole
blood (range 2-56%). OH-PCBs constitute
a significantly more important proportion of
the total chlorinated phenolic compounds in
Inuit as compared to the general population
pooled sample, in which OH-PCBs repre-
sent only 1.2% ofthe estimated total.
The mean concentration ofthe five main
OH-PCBs (1.47 ng/g) in Inuit samples is
slightly higher than that ofa Swedish general
population cohort (1.0 ng/g) (31). The
Swedish data have been adjusted to whole
blood wet weight equivalents. It was expect-
ed that levels ofOH-PCBs in Inuitwould be
higher than those found because the mean
PCB levels in plasma were 3 times that of
this particular Swedish population, and an
average of 30 times (range 2.5-133) that of
the southern Quebec pooled sample. The
range of the sum of these five congeners in
the Swedish study (0.35-1.65 ng/g) is small
as compared to concentrations in the Inuit
population, which range from 0.059 to 7.07
ng/g plasma wet weight levels ofOH-PCBs.
The higher levels ofOH-PCBs are likely due
to the higher levels of parent PCBs.
OH-PCBs were significantly correlated with
PCBs (r= 0.84, p < 0.005), as expected.
The strong linear relationship observed
between concentrations of PCBs and their
metabolites suggests that no changes in
enzyme activity affecting the rate of forma-
tion or saturation of OH-PCBs binding to
plasma proteins are taking place for this
range of PCB exposure. The concentration
of total quantitated chlorinated phenolic
compounds was < 2% of the theoretical
molar circulating concentration of TTR in
an average human (35). Thus, it is not likely
that the concentration of total chlorinated
phenolic compounds reached the carrying
capacity of the blood, assuming that Inuit
have similar TTR concentrations as the pub-
lished values from other populations (35).
Women had lower mean concentrations
ofall phenolic compounds quantitated than
men. The generally lower levels in women
may result from the loss of OH-PCBs and
PCBs through lactation because both have
been identified in milk (36-38). Both
OH-PCBs and PCBs were significantly cor-
related with age (r = 0.68 and 0.78, respec-
tively; p < 0.05). The increase of both PCB
and OH-PCB concentrations with age may
be due to the increased exposure with age
(elders' preference for traditional foods), a
slow excretion rate of PCBs that prevents
steady state from being achieved, or both. A
positive association between age and PCB
levels in breast milk was reported previously
in southern Quebec women (39) and in
Inuit adults from Nunavik (22).
The concentration ofomega-3 fatty acids
in plasma phospholipids is a good indicator
offish intake (40Q. In the course ofthe Sante
Quebec Health Survey, polyunsaturated
fatty acid analysis was performed on plasma
samples obtained from 492 Inuit adults.
There was a strong association between
omega-3 fatty acid content in plasma phos-
pholipids and the age of the participants,
with mean (geometric) concentrations of
6.4% [95% confidence interval (CI),
5.9-6.9]; 8.7% (CI, 8.2-9.3); and 12.2%
(11.5-13.0) for the 18-24 year, 25-44 year,
and 45-74 year age groups, respectively
(Fisher exact test: p < 0.0001) (41). Thus, an
increase in the intake of traditional foods
with age is indicated, and is probably partly
responsible for the increase in PCBs with
age. However, indications ofincreasing con-
centration of PCBs with age in other popu-
lations suggest that slow excretion ofPCBs is
also important.
The main OH-PCBs identified in previ-
ous studies were also the dominating con-
geners in the Inuit population (Figure 2).
The major metabolite in 21 of the 30 sam-
ples analyzed was 4-OH-CB109. This was
not the major metabolite found in the study
by Bergman et al. (14), but it was later iden-
tified by Klasson-Wehler et al. (31) as the
dominant OH-PCB in another study of
human plasma. The-probable mechanism of
formation ofthis metabolite is direct oxygen
insertion into CB-109 or an NIH shift ofCl
through an arene oxide intermediate ofCB-
118 or CB105. CB118 and CB105 are
major congeners of Aroclor mixtures,
whereas CB-109 represents only a fraction
of a percent of the Aroclor mixture; there-
fore, the NIH shift mechanism is more like-
ly, and occurs in the mink and the mouse
(42). The majority of metabolites were
highly correlated to all PCB congeners,
making it impossible to determine the most
probable precursors by correlation analysis.
For example, 4-OH-CB109 was significant-
ly correlated to both CB105 and CB1 18
(r= 0.67 and 0.72, p < 0.005). The correla-
tion coefficients for 4-OH-CB109 and
unrelated PCBs, such as CB153 and
CB187, were equally high (0.77 and 0.71,
p < 0.005). This was true for the majority of
the identified metabolites and the major
PCBs in the Inuit whole blood samples.
The main metabolite in most of the
remaining samples was 4-OH-CB187,
which was previously identified as the major
metabolite in a Swedish population (14).
This compound was also identified as the
main metabolite for the southern Quebec
pooled sample and in other species including
polar bears (33) and albatrosses (32). This
metabolite is most likely formed from the
metabolism ofCB183 and/or CB187, which
represent 2 and 5%, respectively, of the
Aroclor 1254 mixture (43).
The OH-PCB pattern present in the
chlorinated phenolic compound fraction in
plasma is complex and it is difficult to gener-
alize patterns in humans from such a small
data set. The ratio of 4-OH-CB109 to total
OH-PCBs ranged from 0.12 to 0.62 (mean =
0.34) (Figure 3). The remaining congeners in
the Inuit all composed similar proportions of
total OH-PCBs as compared to the southern
population. The ratio of the five main con-
geners to CB153 in the southern pooled sam-
ples was within the range ofthose determined
for the Inuit samples, except for 4-OH-
CB187, where the southern pooled sample
was higher than all ofthe Inuitsamples.
A number of factors, which include
exposure to different proportions of precur-
sor PCBs, alteration of metabolism rates by
induction of hepatic enzymes, inhibition of
the metabolizing enzymes and the protein-
binding specificity of the plasma, may all
influence the retention of hydroxylated
metabolites. Genetic diversity among indi-
viduals and populations may also influence
the metabolism rates and binding specificity.
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To evaluate the toxicologic significance
of the phenolic fraction, the main com-
pounds must be identified, accurately quan-
titated, and toxicologic studies must be
undertaken to evaluate the effects of these
compounds on thyroid hormone and retinol
homeostasis and binding at receptor sites.
PCP remains the dominating phenolic com-
pound in Inuit whole blood, even more so
for the southern Quebec pooled sample.
Concentrations ofPCP in most ofthe sam-
ples far exceeded the main OH-PCBs. Other
compounds, such as the unknown chlorinat-
ed compound, will be researched further to
elucidate structure and possible roles in dis-
ruption ofthyroid hormone transport.
In condusion, total OH-PCB concentra-
tions were 11 and 33% oftotal PCB concen-
trations in Inuit and a southern Quebec
pooled sample ofwhole blood, respectively.
Both total PCB and total OH-PCB geomet-
ric mean concentrations were higher for
Inuit than for the southern Quebec pooled
sample and the current literature values (31).
Increased concentrations resulted in increased
OH-PCB levels in Inuit blood, but the ratio
ofmetabolites to PCBs was not as high as that
found for the southern Quebec pooled sam-
ple. Unlike PCBs, the pattern ofOH-PCBs
was not consistent among individuals. Three
different congeners alternated as the domi-
nant metabolite of PCBs in the 30 samples
analyzed. A larger study would help eluci-
date the reasons for the pattern variability,
the lower ratio of OH-PCBs to PCBs in
Inuit, and the possible differences between
the sexes. PCP was the dominant chlorinat-
ed phenolic compound in the majority of
the samples and must be included in future
studies that may be evaluating the effects of
phenolic compounds on circulating levels of
thyroid hormones and vitamin A.
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